Comprehensive Psychiatry
Volume 41, Issue 1 , Pages 63-69 , January 2000

Assessment of social functioning in depression

  • M. Bosc

      Affiliations

    • Corresponding Author InformationAddress reprint requests to M. Bosc, M.D., 4 Rue du Repos, 66 700 Argeles sur Mer, France.

References 

  1. Weissman MM. The assessment of social functioning. A review of techniques. Arch Gen Psychiatry. 1975;32:357–365
  2. Weissman MM, Klerman GL, Paykel ES, Prusoff B, Hanson B. Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry. 1974;30:771–778
  3. Paykel ES, Weissman MM, Prusoff BA. Social maladjustment and severity of depression. Compr Psychiatry. 1978;19:121–128
  4. Leader JB, Klein DN. Social adjustment in dysthymia, double depression and episodic major depression. J Affect Disord. 1996;37:91–101
  5. Angst J. How recurrent and predictable is depressive illness?. In:  Montgomery SA,  Rouillon F editor. Long Term Treatment of Depression. Chichester, UK: Wiley; 1992;p. 1–13
  6. Stefos G, Bauwens F, Staner L, Pardoen D, Mendlewicz J. Psychosocial predictors of major affective recurrences in bipolar disorder: a 4-year longitudinal study of patients on prophylactic treatment. Acta Psychiatr Scand. 1996;93:420–426
  7. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11–19
  8. Dubini A, Bosc M, Polin V. Do noradrenaline and serotonin differentially affect social motivation and behaviour?. Eur Neuropsychopharmacol. 1997;7(1 Suppl):S49–S55
  9. Dubini A, Bosc M, Polin V. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. J Psychopharmacol. 1997;11(4 Suppl):S17–S23
  10. Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal JH, et al.  Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull. 1991;27:321–330
  11. Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ, et al.  Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull. 1993;29:389–396
  12. Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry. 1996;53:117–128
  13. Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998;59(14 Suppl):11–14
  14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  15. Beck AT. Cognitive Therapy and Emotional Disorders. In: New York, NY: International Universities Press; 1976;p. 116–119
  16. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976;33:1111–1115
  17. Möller HJ, von Zerssen D. Self-rating procedures in the evaluation of antidepressants. Psychopathology. 1995;28:291–306
  18. Clark AW. The Personality and Social Network Adjustment Scale. Hum Relat. 1968;21:85–96
  19. Cook P, Josephs P. The Community Adaptation Schedule and the California Psychological Inventory: a validational study with college students. Community Ment Health J. 1970;6:366–370
  20. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  21. McHomey CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263
  22. Souetre E, Martin P, Lozet H, Monteban H. Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants. Int Clin Psychopharmacol. 1996;11:45–52
  23. Gurland BJ, Yorkston NJ, Stone AR, Frank JD, Fleiss JL. The Structured and Scaled Interview to Assess Maladjustment (SSIAM). Description, rationale and development. Arch Gen Psychiatry. 1972;27:259–264
  24. Gurland BJ, Yorkston NJ, Goldberg K, Fleiss JL, Sloane RB, Cristol AH. The Structured and Scaled Interview to Assess Maladjustment (SSIAM). Factor analysis, reliability, and validity. Arch Gen Psychiatry. 1972;27:264–267
  25. Weissman MM, Paykel ES. The Depressed Woman: A Study of Social Relationships. Chicago, IL: University of Chicago Press; 1974;
  26. Kocsis JH, Allen JF, Voss C, Mason BJ, Mann JJ, Sweeney J. Imipramine and social-vocational adjustment in chronic depression. Am J Psychiatry. 1988;145:997–999
  27. Friedman RA, Markowitz JC, Parides M, Kocsis JH. Acute response of social functioning in dysthymic patients with desipramine. J Affect Disord. 1995;34:85–88
  28. Nierenberg AA, Grossbard SJ, Fava M, Rosenbaum JF. Social adjustment does not predict depressive relapse during continuation fluoxetine therapy. J Affect Disord. 1995;34:73–77
  29. Bosc M, Dubini A, Polin V. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmocol. 1997;7(1 Suppl):S57–S70
  30. Massana J, Möller H-J, Burrows GD, Montenegro RM. Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder. Int Clin Psychopharmacol. 1999;14:73–80
  31. Massana J. Reboxetine vs fluoxetine: an overview of efficacy and tolerability. J Clin Psychiatry. 1998;59(14 Suppl):8–10
  32. Montgomery SA. Reboxetine: additional benefits to the depressed patient. J Psychopharmacol. 1997;11(4 Suppl):S9–S15
  33. Guilford JP, Fruchter B. Fundamental Statistics in Psychology and Education. In: Singapore, Singapore: McGraw-Hill; 1981;p. 308–311
  34. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976;33:1111–1115
  35. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL. The enduring psychosocial consequences of mania and depression. Am J Psychiatry. 1993;150:720–727
  36. Carlsson A, Corrodi H, Fuxe K, Hokfelt T. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-ethyl-metathyramine. Eur J Clin Pharmacol. 1969;5:357–366
  37. Maas JW. Biogenic amines and depression. Arch Gen Psychiatry. 1975;32:1357–1361
  38. Weissman MM. Beyond symptoms: social functioning and the new antidepressants. J Psychopharmacol. 1997;11(4 Suppl):S5–S8

PII: S0010-440X(00)90133-0

Comprehensive Psychiatry
Volume 41, Issue 1 , Pages 63-69 , January 2000

Article Tools